A chemical found in tumors may help stop tumor growth, according to a new study.
It's happening: as early as later this year, the gene-editing power tool CRISPR could be used in its first ever human trial.
An international team of researchers has seen "extraordinary" results using patients' own immune cells to fight cancer. In one trial, 94 percent of patients with acute lymphoblastic leukaemia saw their symptoms disappear entirely.
